BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33769359)

  • 1. Response to Letter to the Editor: Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
    Cao JL; Eisengart J
    J Glaucoma; 2021 Apr; 30(4):e190-e191. PubMed ID: 33769359
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
    Sharma S; Gupta R
    J Glaucoma; 2021 Apr; 30(4):e190. PubMed ID: 33596022
    [No Abstract]   [Full Text] [Related]  

  • 3. Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for eyes with uveitis and glaucoma.
    Ansari H; Kempen JH
    Am J Ophthalmol; 2010 May; 149(5):699-700. PubMed ID: 20399922
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term Outcomes of Glaucoma Drainage Implants in Uveitic Eyes With Fluocinolone Acetonide Implants.
    Cao JL; Srivastava SK; Lowder CY; Sharma S; Baynes K; Eisengart J
    J Glaucoma; 2020 Sep; 29(9):789-793. PubMed ID: 32404619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Ahmed Glaucoma Valve Placement, Intravitreal Fluocinolone Acetonide Implantation and Cataract Extraction for Chronic Uveitis.
    Chang IT; Gupta D; Slabaugh MA; Vemulakonda GA; Chen PP
    J Glaucoma; 2016 Oct; 25(10):842-846. PubMed ID: 27300641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
    Malone PE; Herndon LW; Muir KW; Jaffe GJ
    Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis.
    Bollinger K; Kim J; Lowder CY; Kaiser PK; Smith SD
    Ophthalmology; 2011 Oct; 118(10):1927-31. PubMed ID: 21652079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert).
    Hennein L; Hou J; Stewart JM; Lowry EA; Jiang Z; Enanoria WT; Han Y
    J Glaucoma; 2016 Sep; 25(9):e772-6. PubMed ID: 27552497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Combined Retisert and Ahmed Glaucoma Valve for Medically Uncontrolled Uveitis and Glaucoma.
    Wan KH; Lam DSC
    J Glaucoma; 2017 Jul; 26(7):683. PubMed ID: 28333898
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Surgical Outcome After Ahmed Valve Implantation for Patients With and Without Fluocinolone Intravitreal Implant (Retisert).
    Lowry EA; Hennein L; Han Y
    J Glaucoma; 2017 Jul; 26(7):684. PubMed ID: 28333897
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ; Carlson AN; Jaffe GJ
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes in childhood uveitic glaucoma.
    Bohnsack BL; Freedman SF
    Am J Ophthalmol; 2013 Jan; 155(1):134-42. PubMed ID: 23036573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature.
    Ramdas WD; Pals J; Rothova A; Wolfs RCW
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):143-151. PubMed ID: 30310971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis.
    Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P
    Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ahmed glaucoma drainage implant surgery in the management of refractory uveitic glaucoma: Long-term follow up.
    Valenzuela F; Oportus MJ; Pérez CI; Mellado F; Cartes C; Villarroel F; López-Ponce D; López-Solís R; Traipe L
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):431-438. PubMed ID: 29970261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Uveitis and Outcomes of Glaucoma Drainage Implant Surgery: A Meta-Analysis.
    Chaku M; Bajwa A; Lee JK; Netland PA
    Ocul Immunol Inflamm; 2020 Jul; 28(5):833-838. PubMed ID: 31418636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
    Dayani PN; Chow J; Stinnett SS; Jaffe GJ
    Am J Ophthalmol; 2011 Nov; 152(5):849-56.e1. PubMed ID: 21794844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma.
    Dhanireddy S; Kombo NC; Payal AR; Freitas-Neto CA; Preble J; Foster CS
    Ocul Immunol Inflamm; 2017 Dec; 25(6):767-774. PubMed ID: 27230295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.